Belumosudil for treating chronic graft-versus-host disease after 2 or more systemic treatments in people 12 years and over

Final draft guidance

Final draft guidance (PDF 256 KB)

Committee papers (PDF 2.2 MB)

Draft guidance

Draft guidance (online commenting)

Draft guidance (PDF version) (PDF 308 KB)

Public committee slides (PDF 1.51 MB)

Committee papers Equality Impact Assessment (PDF 158 KB)

Committee meeting: 2

Final scope (PDF 215 KB)

Draft scope and provisional stakeholder list comments table (post-referral) (PDF 512 KB)

Equality impact assessment (Scoping) (PDF 124 KB)

Topic selection

Draft matrix pre referral (PDF 166 KB)